mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.3 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.3 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.33 |
0.3 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.3 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |